British Journal of Haematology · 2023 · 80 citations · 128 references
MedicineHematologyHematopathologyHemostasisTransfusion MedicineClinical HematologyHemostatic DisordersPlatelet DisordersThrombosisThrombosis ManagementThrombotic DisordersComplement-mediated Thrombotic MicroangiopathyMicroangiopathic Hemolytic AnemiaThrombosis In Hemolytic Disorders
The objective of this guideline is to provide healthcare professionals with clear, up-to-date and practical guidance on the management of thrombotic thrombocytopenic purpura (TTP) and related thrombotic microangiopathies (TMAs), including complement-mediated haemolytic uraemic syndrome (CM HUS); these are defined by thrombocytopenia, microangiopathic haemolytic anaemia (MAHA) and small vessel thrombosis. Within England, all TTP cases should be managed within designated regional centres as per NHSE commissioning for highly specialised services.
128
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
Gallia G. Levy, William C. Nichols, Eric C.‐Y. Lian et al. · Nature · 2001 · 1.8K citations · Full text
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text